日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A phase II clinical trial of sorafenib in androgen-independent prostate cancer

索拉非尼治疗雄激素非依赖性前列腺癌的 II 期临床试验

William L Dahut, Charity Scripture, Edwin Posadas, Lokesh Jain, James L Gulley, Philip M Arlen, John J Wright, Yunkai Yu, Liang Cao, Seth M Steinberg, Jeanny B Aragon-Ching, Jürgen Venitz, Elizabeth Jones, Clara C Chen, William D Figg

Exploration of Structure-Activity Relationship of Aromatic Aldehydes Bearing Pyridinylmethoxy-Methyl Esters as Novel Antisickling Agents

含吡啶甲氧基甲酯的芳香醛作为新型抗镰状剂的构效关系探索

Piyusha P Pagare, Mohini S Ghatge, Qiukan Chen, Faik N Musayev, Jurgen Venitz, Osheiza Abdulmalik, Yan Zhang, Martin K Safo

Discovery of Second-Generation NLRP3 Inflammasome Inhibitors: Design, Synthesis, and Biological Characterization

第二代 NLRP3 炎症小体抑制剂的发现:设计、合成和生物学表征

Yuqi Jiang, Liu He, Jakob Green, Hallie Blevins, Chunqing Guo, Sulay Harsiddhbhai Patel, Matthew S Halquist, MaryPeace McRae, Jürgen Venitz, Xiang-Yang Wang, Shijun Zhang

Rational modification of vanillin derivatives to stereospecifically destabilize sickle hemoglobin polymer formation

对香草醛衍生物进行合理修饰,以立体特异性地破坏镰状血红蛋白聚合物的形成

Deshpande, Tanvi M; Pagare, Piyusha P; Ghatge, Mohini S; Chen, Qiukan; Musayev, Faik N; Venitz, Jurgen; Zhang, Yan; Abdulmalik, Osheiza; Safo, Martin K

Rational design of pyridyl derivatives of vanillin for the treatment of sickle cell disease

香兰素吡啶基衍生物的合理设计用于治疗镰状细胞病

Piyusha P Pagare, Mohini S Ghatge, Faik N Musayev, Tanvi M Deshpande, Qiukan Chen, Courtney Braxton, Solyi Kim, Jürgen Venitz, Yan Zhang, Osheiza Abdulmalik, Martin K Safo

Design, Synthesis, and Biological Evaluation of Ester and Ether Derivatives of Antisickling Agent 5-HMF for the Treatment of Sickle Cell Disease

抗镰状细胞病剂 5-HMF 的酯和醚衍生物的设计、合成及生物评价

Guoyan G Xu, Piyusha P Pagare, Mohini S Ghatge, Ronni P Safo, Aheema Gazi, Qiukan Chen, Tanya David, Alhumaidi B Alabbas, Faik N Musayev, Jürgen Venitz, Yan Zhang, Martin K Safo, Osheiza Abdulmalik

Phase 1 study evaluating the safety and pharmacokinetics of pralatrexate in relapsed/refractory advanced solid tumors and lymphoma patients with mild, moderate, and severe renal impairment

一项评估普拉曲沙特在复发/难治性晚期实体瘤和淋巴瘤患者(伴有轻度、中度和重度肾功能损害)中的安全性和药代动力学的 I 期研究。

Kelly, Kevin R; Gabrail, Nashat; Weitman, Steven; Sarantopoulos, John; Olszanski, Anthony J; Edenfield, William; Venitz, Jurgen; Reddy, Guru; Yang, Allen; Hasal, Steven J; Lockhart, A Craig

Monitoring rFVIII prophylaxis dosing using global haemostasis assays

利用整体止血试验监测rFVIII预防性用药剂量

Al Hawaj, M A; Martin, E J; Venitz, J; Barrett, J C; Kuhn, J G; Nolte, M E; Brophy, D F

Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenib

与 VEGFR2 基因型相关的高血压和手足皮肤反应,以及贝伐珠单抗和索拉非尼治疗后临床疗效的改善

Jain, Lokesh; Sissung, Tristan M; Danesi, Romano; Kohn, Elise C; Dahut, William L; Kummar, Shivaani; Venzon, David; Liewehr, David; English, Bevin C; Baum, Caitlin E; Yarchoan, Robert; Giaccone, Giuseppe; Venitz, Jürgen; Price, Douglas K; Figg, William D

Determination of PF-04928473 in human plasma using liquid chromatography with tandem mass spectrometry

采用液相色谱-串联质谱法测定人血浆中PF-04928473的含量

Jain, Lokesh; Gardner, Erin R; Venitz, Jürgen; Giaccone, Giuseppe; Houk, Brett E; Figg, William D